Skip to main content
Jenscare Scientific Co., Ltd. logo

Jenscare Scientific Co., Ltd. — Investor Relations & Filings

Ticker · 9877 ISIN · CNE100005KC9 HKEX Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country HK Hong Kong
Listing HKEX 9877

About Jenscare Scientific Co., Ltd.

http://www.jenscare.com

Jenscare Scientific Co., Ltd. is a medical device company dedicated to the research, development, and commercialization of innovative interventional products for the treatment of structural heart diseases. The company focuses on addressing unmet clinical needs by developing high-quality, safe, and effective therapeutic solutions. Jenscare has established a comprehensive product portfolio through independent innovation, offering a series of treatment solutions for various structural heart conditions. Core products include the LuX-Valve and Ken-Valve transcatheter valve systems. The company operates a full-cycle R&D function, spanning from the discovery of medical needs through product development to commercialization.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT THE TWELVE-MONTH CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LuX-Valve Plus EU TRINITY STUDY PRESENTED AT EuroPCR 2026, DEMONSTRATING LARGE SIZE ADVANTAGES WITH PRO
Regulatory Filings Classification · 85% confidence The document is a voluntary announcement on the HKEx platform by Jenscare Scientific regarding clinical follow-up results of a medical device study. It contains product and clinical data, not financial statements, earnings figures, or any of the other specialized report types. It is not an earnings release, investor presentation, dividend notice, share issue update, or any management report. As such it falls under the miscellaneous regulatory announcement category.
2026-05-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 100% confidence The document is a monthly return filing to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for the month ended 30 April 2026. It details movements in authorised/registered share capital, issued shares, treasury shares, and public float sufficiency confirmation. It is a regulatory compliance report related to share capital and public float requirements under HKEX Listing Rules Chapter 19B. The document is not a financial report, earnings release, or management discussion. It is a regulatory filing providing required disclosures about share capital and share movements. It does not announce or attach a report but is itself a regulatory submission. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-05-07 English
NOTICE OF 2025 ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a formal Notice of the 2025 Annual General Meeting (AGM) of Jenscare Scientific Co., Ltd., detailing the meeting date, venue, agenda items (ordinary and special resolutions), proxy arrangements, and procedural notes for shareholders. It is not the full annual report nor a results announcement, but rather the official notice for convening an AGM. This matches the definition of AGM Information (AGM-R).
2026-04-28 English
PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 28 MAY 2026
Proxy Solicitation & Information Statement Classification · 96% confidence The document is a proxy form (“Proxy Form for the 2025 Annual General Meeting”) used by shareholders to appoint proxies and vote at the AGM. This falls under proxy solicitation materials rather than the meeting’s results or the report itself. Therefore it should be classified as Proxy Solicitation & Information Statement (Code: PSI).
2026-04-28 English
2025 Annual Report
Annual Report Classification · 98% confidence The document is titled “2025 ANNUAL REPORT” for Jenscare Scientific Co., Ltd. and includes a full table of contents with sections such as Definitions, Corporate Information, Chief Executive Officer’s Statement, Management Discussion and Analysis, Directors’ Report, Independent Auditor’s Report, and complete consolidated financial statements and notes. It clearly constitutes a comprehensive yearly report covering full financial performance and corporate disclosures—not merely an announcement or summary—thus matching the Annual Report category. FY 2025
2026-04-28 English
(1) 2025 REPORT OF THE BOARD OF DIRECTORS (2) 2025 AUDITED FINANCIAL STATEMENTS (3) 2025 ANNUAL REPORT (4) 2025 PROFIT DISTRIBUTION PLAN (5) RE-APPOINTMENT OF AUDITOR (6) REMUNERATION OF DIRECTORS (7)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a shareholder circular containing the Notice of the 2025 Annual General Meeting, agenda items, explanatory statements on resolutions, proxy form instructions, and information to solicit votes. This matches the definition of a Proxy Solicitation & Information Statement (materials sent to shareholders to provide meeting information and request votes).
2026-04-28 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.